Who invested in Omthera Pharmaceuticals?
Omthera Pharmaceuticals's investors include Sofinnova Partners and New Enterprise Associates.
United States · Funded startup
4 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Omthera Pharmaceuticals and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$60Mraised across 4 rounds since 2009, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $18M sold, first sale Feb 2013
Reported by fiercebiotech.comSEC filing: $34M sold, first sale Feb 2011
No investor was named in the report.
From a historical funding recordSEC filing: $2.2M sold, first sale Nov 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Omthera Pharmaceuticals's investors include Sofinnova Partners and New Enterprise Associates.
Omthera Pharmaceuticals has raised $60M across 4 rounds since 2009.
Omthera Pharmaceuticals's most recent round was a Debt of $18M in Feb 2013.
Omthera Pharmaceuticals's largest round on record is $34M (Series B), in Mar 2011.
Omthera Pharmaceuticals's first round on record, in Mar 2010, was backed by Sofinnova Partners.
Omthera Pharmaceuticals's latest named round is a Debt, in Feb 2013.
Omthera Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.